Our work on lung health and NCDs
The Union calls for policies and actions that contribute to improved lung health globally. We promote the importance of poverty reduction and address the social determinants of health to improve health outcomes worldwide.
The Union's priority areas are:
In collaboration with the International Study of Asthma and Allergies in Childhood, The Union founded the Global Asthma Network (GAN) which published The Global Asthma Report 2018, an 88 page cutting edge State-of-the-Art report, with contributions from 53 experts around the globe.
Lung Health Union News
The second United Nations high-level meeting on the fight to end TB: action is needed to turn the tide by 2030
An Editorial in the September issue of PHA highlights the need to accelerate progress towards TB elimination.
Tackling TB in Europe: treatment gaps and deteriorating treatment availability is undermining progress
An Editorial in a forthcoming issue of the IJTLD highlights the need for access to medications for drugs for TB in Europe. The preprint is free to read.
Community perspective on child-friendly medications for drug-resistant TB: importance, priorities and advocacy
An Editorial in a forthcoming issue of the IJTLD highlights the need for child-friendly medications for drug-resistant TB. The preprint is free to read.
An article in a forthcoming issue of PHA assesses point-of-care (POC) diagnostics for the early detection of advanced HIV disease (AHD), and in its presence, TB and cryptococcosis, in Democratic Republic of the Congo (DRC)
The adult and child lung health section
Recently, this group of Union members collaborated with The Union’s Director of Lung Health to create The Union’s Strategic Plan for Lung Health 2020-2025. Two broad themes emerged as priorities: lung health across the life course; and lung health and well-being after TB.
Linked to the Strategic Plan, the section organised popular member webinars on ‘Lungs past and future: recognising and treating respiratory disease arising in early life’ and ‘Post TB lung disease – current state of the science.’